179 related articles for article (PubMed ID: 22202123)
21. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.
Forestal CA; Gil H; Monfett M; Noah CE; Platz GJ; Thanassi DG; Benach JL; Furie MB
Microb Pathog; 2008 Jun; 44(6):512-23. PubMed ID: 18304778
[TBL] [Abstract][Full Text] [Related]
22. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
23. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
[TBL] [Abstract][Full Text] [Related]
25. Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.
Cole LE; Santiago A; Barry E; Kang TJ; Shirey KA; Roberts ZJ; Elkins KL; Cross AS; Vogel SN
J Immunol; 2008 May; 180(10):6885-91. PubMed ID: 18453609
[TBL] [Abstract][Full Text] [Related]
26. Francisella tularensis phagosomal escape does not require acidification of the phagosome.
Clemens DL; Lee BY; Horwitz MA
Infect Immun; 2009 May; 77(5):1757-73. PubMed ID: 19237528
[TBL] [Abstract][Full Text] [Related]
27. Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.
Santiago AE; Cole LE; Franco A; Vogel SN; Levine MM; Barry EM
Vaccine; 2009 Apr; 27(18):2426-36. PubMed ID: 19368784
[TBL] [Abstract][Full Text] [Related]
28. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
29. Molecular complexity orchestrates modulation of phagosome biogenesis and escape to the cytosol of macrophages by Francisella tularensis.
Asare R; Abu Kwaik Y
Environ Microbiol; 2010 Sep; 12(9):2559-86. PubMed ID: 20482590
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants.
Ozanic M; Marecic V; Lindgren M; Sjöstedt A; Santic M
Microbes Infect; 2016 Dec; 18(12):768-776. PubMed ID: 27477000
[TBL] [Abstract][Full Text] [Related]
31. Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS.
Schulert GS; McCaffrey RL; Buchan BW; Lindemann SR; Hollenback C; Jones BD; Allen LA
Infect Immun; 2009 Apr; 77(4):1324-36. PubMed ID: 19204089
[TBL] [Abstract][Full Text] [Related]
32. Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
Freudenberger Catanzaro KC; Lahmers KK; Allen IC; Inzana TJ
PLoS One; 2022; 17(3):e0259807. PubMed ID: 35275912
[TBL] [Abstract][Full Text] [Related]
33. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
34. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ
PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343
[TBL] [Abstract][Full Text] [Related]
35. Proteome study of Francisella tularensis live vaccine strain-containing phagosome in Bcg/Nramp1 congenic macrophages: resistant allele contributes to permissive environment and susceptibility to infection.
Kovárová H; Halada P; Man P; Golovliov I; Krocová Z; Spacek J; Porkertová S; Necasová R
Proteomics; 2002 Jan; 2(1):85-93. PubMed ID: 11788995
[TBL] [Abstract][Full Text] [Related]
36. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
Cowley SC; Sedgwick JD; Elkins KL
J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
[TBL] [Abstract][Full Text] [Related]
37. Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice.
Hartley G; Taylor R; Prior J; Newstead S; Hitchen PG; Morris HR; Dell A; Titball RW
Vaccine; 2006 Feb; 24(7):989-96. PubMed ID: 16257097
[TBL] [Abstract][Full Text] [Related]
38.
Brock SR; Parmely MJ
Front Cell Infect Microbiol; 2017; 7():523. PubMed ID: 29312899
[No Abstract] [Full Text] [Related]
39. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
40. Francisella tularensis travels a novel, twisted road within macrophages.
Santic M; Molmeret M; Klose KE; Abu Kwaik Y
Trends Microbiol; 2006 Jan; 14(1):37-44. PubMed ID: 16356719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
